Key result
Risk models offer personalized estimates in older advanced CKD patients but must weigh competing mortality risk.
Why the study?
Incorporating competing risk of death and slower progression into shared decision-making is challenging for older patients with kidney failure, requiring clear guidance on using risk prediction models.
Risk prediction models can provide personalized absolute risk prediction for older patients with advanced CKD, aiding in shared decision-making regarding kidney failure and mortality risks.
May inform shared decisions in older advanced CKD; leaves open prospective validation of competing-risk models.
Older patients represent the most rapidly growing age group presenting with kidney failure. Despite this high incidence, the rate of progression to kidney failure tends to be slower in older individuals, and the competing risk of death before the development of kidney failure is a more significant consideration in older patients compared with younger counterparts. Incorporating these concepts of risk is challenging in shared decision-making discussions between clinicians, older patients, and their families. Risk prediction models are rapidly increasing in nephrology and have the potential to provide personalized absolute risk prediction for patients with advanced chronic kidney disease; however, there are several considerations of these models relevant to older patient populations. This review discusses metrics for assessing risk prediction models, examines key models for predicting kidney failure and mortality risk in older patients with advanced chronic kidney disease, and provides guidance for how best to interpret and use these models to support personalized decision-making processes with older patients.
No takes yet. Share an insight, caveat, or question.
Siriwardana et al. (2025) conducted a review in advanced chronic kidney disease. Risk prediction models was evaluated. Risk prediction models for older patients with advanced chronic kidney disease can provide personalized absolute risk prediction but require careful consideration of the competing risk of death.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: